XellSmart Bio

XellSmart is a biotechnology company dedicated to developing scalable, low-cost, allogeneic stem cell therapies derived from induced pluripotent stem cells (iPSCs) to treat major degenerative diseases with high unmet medical need—such as ALS and Parkinson’s disease. With in-house GMP manufacturing, a state-of-the-art R&D center, and FDA-recognized clinical programs, we are transforming cutting-edge science into accessible, off-the-shelf regenerative solutions. This page is dedicated to sharing our journey, achievements, and breakthroughs as we work to reshape the future of neurological care.